Neuroinflammation, Mast Cells, and Glia: Dangerous Liaisons

Neuroscientist

Volumn 23, Issue 5, 2017, Pages 478-498

  Skaper, Stephen D ^a   Facci, Laura ^a   Zusso, Morena ^a   Giusti, Pietro ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

astrocytes; immunosenescence; mast cells; microglia; neuro immune; neurodegeneration; neuroinflammation; neuropathic pain; oligodendrocytes

Indexed keywords

ALZHEIMER DISEASE; BLOOD BRAIN BARRIER; BLOOD NERVE BARRIER; CELL COMMUNICATION; CELL INTERACTION; CHRONIC DISEASE; GLIA; HUMAN; IMMUNOSENESCENCE; MAST CELL; NERVOUS SYSTEM INFLAMMATION; NEUROPATHIC PAIN; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; ENCEPHALITIS; METABOLISM; PATHOLOGY; PHYSIOLOGY;

CYTOKINE;

ANIMALS; CELL COMMUNICATION; CYTOKINES; ENCEPHALITIS; HUMANS; MAST CELLS; NEUROGLIA;

EID: 85029496384     PISSN: 10738584     EISSN: 10894098     Source Type: Journal    
DOI: 10.1177/1073858416687249     Document Type: Review

References (216)

1. Aguirre A, Maturana CJ, Harcha PA, Sáez JC., 2013. Possible involvement of TLRs and hemichannels in stress-induced CNS dysfunction via mastocytes, and glia activation. Mediators Inflamm 2013: 893521. doi: 10.1155/2013/893521.
2. Alhouayek M, Muccioli GG,. 2014. Harnessing the anti-inflammatory potential of palmitoylethanolamide. Drug Discov Today 19: 1632-9.
3. Allan D, Fairlie-Clarke KJ, Elliott C, Schuh C, Barnett SC, Lassmann H., 2016. Role of IL-33 and ST2 signalling pathway in multiple sclerosis: expression by oligodendrocytes and inhibition of myelination in central nervous system. Acta Neuropathol Commun 4: 75. doi: 10.1186/s40478-016-0344-1.
4. Amor S, Woodruffe MN,. 2014. Innate and adaptive immune responses in neurodegeneration and repair. Immunology 141: 287-91.
5. Amor S, Peferoen LA, Vogel DY, Breur M, van der Valk P, Baker D, and others. 2014. Inflammation in neurodegenerative diseases-an update. Immunology 142: 151-66.
6. Appel SH, Zhao W, Beers DR, Henkel JS,. 2011. The microglial-motoneuron dialogue in ALS. Acta Myol 30: 4-8.
7. Bankston AN, Mandler MD, Feng Y., 2013. Oligodendroglia and neurotrophic factors in neurodegeneration. Neurosci Bull 29: 216-28.
8. Biber K, Tsuda M, Tozaki-Saitoh H, Tsukamoto K, Toyomitsu E, Masuda T, and others. 2011. Neuronal CCL21 up-regulates microglia P2X4 expression and initiates neuropathic pain development. EMBO J 30: 1864-73
9. Biran V, Cochois V, Karroubi A, Arrang JM, Charriaut-Marlangue C, Héron A., 2008. Stroke induces histamine accumulation and mast cell degranulation in the neonatal rat brain. Brain Pathol 18: 1-9.
10. Borsook D,. 2012. Neurological diseases and pain. Brain 135: 320-44.
11. Brenner T, Soffer D, Shalit M, Levi-Schaffer F., 1994. Mast cells in experimental allergic encephalomyelitis: characterization, distribution in the CNS and in vitro activation by myelin basic protein and neuropeptides. J Neurol Sci 122: 210-3.
12. Brooks TA, Hawkins BT, Huber JD, Egleton RD, Davis TP,. 2005. Chronic inflammatory pain leads to increased blood-brain barrier permeability and tight junction protein alterations. Am J Physiol Heart Circ Physiol 289: H738-43.
13. Buchanan MM, Hutchinson M, Watkins LR, Yin H., 2010. Toll-like receptor 4 in CNS pathologies. J Neurochem 114: 13-27.
14. Bulanova E, Bulfone-Paus S., 2010. P2 receptor-mediated signaling in mast cell biology. Purinergic Signal 6: 3-17.
15. Bulfone-Paus S, Bahri R., 2015. Mast cells as regulators of T cell responses. Front Immunol 6: 394. doi.org/10.3389/fimmu.2015.00394.
16. Burnstock G,. 2016. Purinergic mechanisms and pain. Adv Pharmacol 75: 91-137.
17. Calcia MA, Bonsall DR, Bloomfield PS, Selvaraj S, Barichello T, Howes OD,. 2016. Stress and neuroinflammation: a systematic review of the effects of stress on microglia and the implications for mental illness. Psychopharmacology (Berl) 233: 1637-50.
18. Castanon N, Luheshi G, Layé S., 2015. Role of neuroinflammation in the emotional and cognitive alterations displayed by animal models of obesity. Front Neurosci 9: 229. doi: 10.3389/fnins.2015.00229.
19. Castellheim A, Brekke OL, Espevik T, Harboe M, Mollnes TE,. 2009. Innate immune responses to danger signals in systemic inflammatory response syndrome and sepsis. Scand J Immunol 69: 479-91.
20. Chan-Ling T, Hughes S, Baxter L, Rosinova E, McGregor I, Morcos Y, and others. 2007. Inflammation and breakdown of the blood-retinal barrier during "physiological aging" in the rat retina: a model for CNS aging. Microcirculation 14: 63-76.
21. Chen YJ, Hill S, Huang H, Taraboletti A, Cho K, Gallo R, and others. 2014. Inflammation triggers production of dimethylsphingosine from oligodendrocytes. Neuroscience 279: 113-21.
22. Choudhuri K, Llodrá J, Roth EW, Tsai J, Gordo S, Wucherpfennig KW, and others. 2014. Polarized release of T-cell-receptor-enriched microvesicles at the immunological synapse. Nature 507: 118-23.
23. Christophi GP, Gruber RC, Panos M, Christophi RL, Jubelt B, Massa PT,. 2012. Interleukin-33 upregulation in peripheral leukocytes and CNS of multiple sclerosis patients. Clin Immunol 142: 308-19.
24. Christy AL, Walker ME, Hessner MJ, Brown MA,. 2013. Mast cell activation and neutrophil recruitment promotes early and robust inflammation in the meninges in EAE. J Autoimmun 42: 50-61.
25. Compston A, Coles A., 2008. Multiple sclerosis. Lancet 372: 1502-17.
26. Comrie WA, Burkhardt JK,. 2016. Action and traction: cytoskeletal control of receptor triggering at the immunological synapse. Front Immunol 7: 68. doi: 10.3389/fimmu.2016.00068.
27. Conti P, Kempuraj D., 2016. Important role of mast cells in multiple sclerosis. Mult Scler Relat Disord 5: 77-80.
28. Corrigan F, Pham CL, Vink R, Blumbergs PC, Masters CL, van den Heuvel C, and others. 2011. The neuroprotective domains of the amyloid precursor protein, in traumatic brain injury, are located in the two growth factor domains. Brain Res 1378: 137-43.
29. Cristino L, Luongo L, Squillace M, Paolone G, Mango D, Piccinin S, and others. 2015. d-Aspartate oxidase influences glutamatergic system homeostasis in mammalian brain. Neurobiol Aging 36: 1890-1902.
30. Cunningham C,. 2013. Microglia and neurodegeneration: the role of systemic inflammation. Glia 61: 71-90.
31. D'Agostino G, La Rana G, Russo R, Sasso O, Iacono A, Esposito E, and others. 2007. Acute intracerebroventricular administration of palmitoylethanolamide, an endogenous peroxisome proliferator-activated receptor-alpha agonist, modulates carrageenan-induced paw edema in mice. J Pharmacol Exp Ther 322: 1137-43.
32. da Silva EZ, Jamur MC, Oliver C., 2014. Mast cell function: a new vision of an old cell. J Histochem Cytochem 62: 698-738.
33. Demir IE, Schorn S, Schremmer-Danninger E, Wang K, Kehl T, Giese NA, and others. 2013. Perineural mast cells are specifically enriched in pancreatic neuritis and neuropathic pain in pancreatic cancer and chronic pancreatitis. PLoS One 8: e60529. doi: 10.1371/journal.pone.0060529.
34. Diakos CI, Charles KA, McMillan DC, Clarke SJ,. 2014. Cancer-related inflammation and treatment effectiveness. Lancet Oncol 15: e493-503. doi: 10.1016/S1470-2045(14)70263-3.
35. Dirckx M, Groeneweg G, van Daele PL, Stronks DL, Huygen FJ,. 2013. Mast cells: a new target in the treatment of complex regional pain syndrome? Pain Pract 13: 599-603.
36. Donath MY,. 2014. Targeting inflammation in the treatment of type 2 diabetes: time to start. Nat Rev Drug Discov 13: 465-76.
37. Done JD, Rudick CN, Quick ML, Schaeffer AJ, Thumbikat P., 2012. Role of mast cells in male chronic pelvic pain. J Urol 187: 1473-82.
38. Eckenhoff RG, Laudansky KF,. 2013. Anesthesia, surgery, illness and Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 47: 162-6.
39. Eggen BJ, Raj D, Hanisch UK, Boddeke HW,. 2013. Microglial phenotype and adaptation. J Neuroimmune Pharmacol 8: 807-23.
40. Ellis A, Bennett DL,. 2014. Neuroinflammation and the generation of neuropathic pain. 2013. Br J Anaesth 111: 26-37.
41. Engler H, Doenlen R, Engler A, Riether C, Prager G, Niemi MB, and others. 2011. Acute amygdaloid response to systemic inflammation. Brain Behav Immun 25: 1384-92.
42. Ertürk A, Mentz S, Stout EE, Hedehus M, Dominguez SL, Neumaier L, and others. 2016. Interfering with the chronic immune response rescues chronic degeneration after traumatic brain injury. J Neurosci. 36: 9962-75.
43. Eskander MA, Ruparel S, Green DP, Chen PB, Por ED, Jeske NA, and others. 2015. Persistent nociception triggered by nerve growth factor (NGF) is mediated by TRPV1 and oxidative mechanisms. J Neurosci 35: 8593-603.
44. Esposito P, Gheorghe D, Kandere K, Pang X, Connolly R, Jacobson S, and others. 2001. Acute stress increases permeability of the blood-brain-barrier through activation of brain mast cells. Brain Res 888: 117-27.
45. Fonken LK, Frank MG, Kitt MM, D'Angelo HM, Norden DM, Weber MD, and others. 2016. The alarmin HMGB1 mediates age-induced neuroinflammatory priming. J Neurosci 36: 7946-56.
46. Forsythe P, Bienenstock J., 2012. The mast cell-nerve functional unit: a key component of physiologic and pathophysiologic responses. Chem Immunol Allergy 98: 196-221.
47. Freeman LC, Ting JP,. 2016. The pathogenic role of the inflammasome in neurodegenerative diseases. J Neurochem 136 (Suppl 1): 29-38.
48. Fullerton JN, Gilroy DW,. 2016. Resolution of inflammation: a new therapeutic frontier. Nat Rev Drug Discov 15: 551-67.
49. Gao YJ, Ji RR,. 2010. Targeting astrocyte signaling for chronic pain. Neurotherapeutics 27: 482-93.
50. Gaudenzio N, Espagnolle N, Mars LT, Liblau R, Valitutti S, Espinosa E., 2009. Cell-cell cooperation at the T helper cell/mast cell immunological synapse. Blood 114: 4979-88.
51. Geppetti P, Nassini R, Materazzi S, Benemei S., 2008. The concept of neurogenic inflammation. BJU Int 101 (Suppl 3): 2-6.
52. Grace PM, Hutchinson MR, Maier SF, Watkins LR,. 2014. Pathological pain and the neuroimmune interface. Nat Rev Immunol 14: 217-31.
53. Grakoui A, Bromley SK, Sumen C, Davis MM, Shaw AS, Allen PM, and others. 1999. The immunological synapse: a molecular machine controlling T cell activation. Science 285: 221-7.
54. Gregory GD, Raju SS, Winandy S, Brown MA,. 2006. Mast cell IL-4 expression is regulated by Ikaros and influences encephalitogenic Th1 responses in EAE. J Clin Invest 116: 1327-36.
55. Griffin RS, Costigan M, Brenner GJ, Ma CH, Scholz J, Moss A, and others. 2007. Complement induction in spinal cord microglia results in anaphylatoxin C5a-mediated pain hypersensitivity. J Neurosci 27: 8699-708.
56. Gritsch S, Lu J, Thilemann S, Wörtge S, Möbius W, Bruttger J, and others. 2014. Oligodendrocyte ablation triggers central pain independently of innate or adaptive immune responses in mice. Nat Commun 5: 5472. doi: 10.1038/ncomms6472.
57. Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, and others. 2013. TREM2 variants in Alzheimer's disease. N Engl J Med 368: 117-27.
58. Gunin AG, Kornilova NK, Vasilieva OV, Petrov VV,. 2011. Age-related changes in proliferation, the numbers of mast cells, eosinophils, and cd45-positive cells in human dermis. J Gerontol A Biol Sci Med Sci 66: 385-92.
59. Hagiyama M, Inoue T, Furuno T, Iino T, Itami S, Nakanishi M, and others. 2013. Increased expression of cell adhesion molecule 1 by mast cells as a cause of enhanced nerve-mast cell interaction in a hapten-induced mouse model of atopic dermatitis. Br J Dermatol 168: 771-8.
60. Hains LE, Loram LC, Weiseler JL, Frank MG, Bloss EB, Sholar P, and others. 2010. Pain intensity and duration can be enhanced by prior challenge: initial evidence suggestive of a role of microglial priming. J Pain 11: 1004-14.
61. Hanisch UK, Kettenmann H., 2007. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 10: 1387-94.
62. Harcha PA, Vargas A, Yi C, Koulakoff AA, Giaume C, Sáez JC,. 2015. Hemichannels are required for amyloid β-peptide-induced degranulation and are activated in brain mast cells of APPswe/PS1dE9 mice. J Neurosci 35: 9526-38.
63. Harvey GK, Toyka KV, Hartung HP,. 1994. Effects of mast cell degranulation on blood-nerve barrier permeability and nerve conduction in vivo. J Neurol Sci 125: 102-9.
64. Hayashi R, Xiao W, Kawamato M, Yuge O, Bennett GJ,. 2011. Systemic glucocorticoid therapy reduces pain and the number of endoneurial tumor necrosis factor-alpha (TNFα)-positive mast cells in rats with a painful peripheral neuropathy. J Pharmacol Sci 106: 559-65.
65. Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, and others. 2015. Neuroinflammation in Alzheimer's disease. Lancet Neurol 14: 388-405.
66. Héron A, Dubayle D., 2013. A focus on mast cells and pain. J Neuroimmunol 264: 1-7.
67. Hickman SE, Kingery ND, Ohsumi TK, Borowsky ML, Wang LC, Means TK, and others 2013. The microglial sensome revealed by direct RNA sequencing. Nat Neurosci 16: 1896-905.
68. Hsieh CL, Koike M, Spusta SC, Niemi EC, Yenari M, Nakamura MC, and others. 2009. A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia. J Neurochem 109: 1144-56.
69. Hu W, Xu L, Pan J, Zheng X, Chen Z., 2004. Effect of cerebral ischemia on brain mast cells in rats. Brain Res 1019: 275-80.
70. Iadecola C, Anrather J., 2011. The immunology of stroke: from mechanisms to translation. Nat Med 17: 796-808.
71. Ito A, Oonuma J., 2006. Direct interaction between nerves and mast cells mediated by the SgIGSF/SynCAM adhesion molecule. J Pharmacol Sci 102: 1-5.
72. Jay GW, Barkin RL,. 2014. Neuropathic pain: etiology, pathophysiology, mechanisms, and evaluations. Dis Mon 60: 6-47.
73. Jensen TS, Baron R, Haanpää M, Kalso E, Loeser JD, Rice AS, and others. 2011. A new definition of neuropathic pain. Pain 152: 2204-5.
74. Ji RR, Xu ZZ, Gao YJ,. 2014. Emerging targets in neuroinflammation-driven chronic pain. Nat Rev Drug Discov 13: 533-48.
75. Jin Y, Silverman AJ, Vannucci SJ,. 2007. Mast cell stabilization limits hypoxic-ischemic brain damage in the immature rat. Dev Neurosci 29: 373-84.
76. Jin Y, Silverman AJ, Vannucci SJ,. 2009. Mast cells are early responders after hypoxia-ischemia in immature rat brain. Stroke 40: 3107-12.
77. Juremalm M, Hjertson M, Olsson N, Harvima I, Nilsson K, Nilsson G., 2000. The chemokine receptor CXCR4 is expressed within the mast cell lineage and its ligand stromal cell-derived factor-1alpha acts as a mast cell chemotaxin. Eur J Immunol 30: 3614-22.
78. Kajihara Y, Murakami M, Imagawa T, Otsuguro K, Ito S, Ohta T., 2010. Histamine potentiates acid-induced responses mediating transient receptor potential V1 in mouse primary sensory neurons. Neuroscience 166: 292-304.
79. Kalesnikoff J, Galli SJ,. 2008. New developments in mast cell biology. Nat Immunol 9: 1215-23.
80. Kalichman MW, Powell HC, Calcutt NA, Mizisin AP,. 1995. Mast cell degranulation and blood-nerve barrier permeability in rat sciatic nerve after 7 days of hyperglycemia. Am J Physiol 268: H740-8.
81. Kamm CP, Uitdehaag BM, Polman CH,. 2014. Multiple sclerosis: current knowledge and future outlook. Eur Neurol 72: 132-41.
82. Kan JI, Mishima S, Kashiwakura JI, Sasaki-Sakamoto T, Seki M, Saito S, and others. 2016. Interleukin-17A expression in human synovial mast cells in rheumatoid arthritis and osteoarthritis. Allergol Int 65: S11-6. doi: 10.1016/j.alit.2016.04.007.
83. Kelleher JH, Tewari D, McMahon SB,. 2017. Neurotrophic factors and their inhibitors in chronic pain treatment. Neurobiol Dis 97: 127-38. doi: 10.1016/j.nbd.2016.03.025.
84. Kerstman E, Ahn S, Battu S, Tariq S, Grabois M., 2013. Neuropathic pain. Handb Clin Neurol 110: 175-87.
85. Kim DH, Do MS,. 2015. BAFF knockout improves systemic inflammation via regulating adipose tissue distribution in high-fat diet-induced obesity. Exp Mol Med 47: e129. doi: 10.1038/emm.2014.98.
86. Kim DY, Hong GU, Ro JY,. 2011. Signal pathways in astrocytes activated by cross-talk between of astrocytes and mast cells through CD40-CD40L. J Neuroinflammation 8: 25. doi: 10.1186/1742-2094-8-25
87. Kolbinger F, Huppertz C, Mir A, Di Padova F., 2016. IL-17A and multiple sclerosis: signaling pathways, producing cells and target cells in the central nervous system. Curr Drug Targets Epub.
88. Klray H, Lindsay SL, Hosseinzadeh S, Barnett SC,. 2016. The multifaceted role of astrocytes in regulating myelination. Exp Neurol 283: 541-9. doi: 10.1016/j.expneurol.2016.03.009.
89. Kobayashi K, Yamanaka H, Fukuoka T, Dai Y, Obata K, Noguchi K., 2008. P2Y12 receptor upregulation in activated microglia is a gateway of p38 signaling and neuropathic pain. J Neurosci 28: 2892-902.
90. Koshinaga M, Katayama Y, Fukushima M, Oshima H, Suma T, Takahata T., 2000. Rapid and widespread microglial activation induced by traumatic brain injury in rat brain slices. J Neurotrauma 17: 185-92.
91. Kritas SK, Saggini A, Cerulli G, Caraffa A, Antinolfi P, Pantalone A, and others. 2014. Impact of mast cells on multiple sclerosis: inhibitory effect of natalizumab. Int J Immunopathol Pharmacol 27: 331-5.
92. Kwon C, Panstruga R, Schulze-Lefert P., 2008. Les liaisons dangereuses: immunological synapse formation in animals and plants. Trends Immunol 29: 159-66.
93. Lange C, Storkebaum E, de Almodóvar CR, Dewerchin M, Carmeliet P., 2016. Vascular endothelial growth factor: a neurovascular target in neurological diseases. Nat Rev Neurol 12: 439-54.
94. Lapilover EG, Lippmann K, Salar S, Maslarova A, Dreier JP, Heinemann U, and others. 2012. Peri-infarct blood-brain barrier dysfunction facilitates induction of spreading depolarization associated with epileptiform discharges. Neurobiol Dis 48: 495-506.
95. Leon A, Buriani A, Dal Toso R, Fabris M, Romanello S, Aloe L, and others. 1994. Mast cells synthesize, store, and release nerve growth factor. Proc Natl Acad Sci U S A 91: 3739-43.
96. Le Thuc O, Blondeau N, Nahon JL, Rovère C., 2015. The complex contribution of chemokines to neuroinflammation: switching from beneficial to detrimental effects. Ann N Y Acad Sci 1351: 127-40.
97. Levy D, Edut S, Baraz-Goldstein R, Rubovitch V, Defrin R, Bree D., 2016. Responses of dural mast cells in concussive and blast models of mild traumatic brain injury in mice: potential implications for post-traumatic headache. Cephalalgia 36: 915-23. doi: 10.1177/0333102415617412.
98. Levy D, Kainz V, Burstein R, Strassman AM,. 2012. Mast cell degranulation distinctly activates trigemino-cervical and lumbosacral pain pathways and elicits widespread tactile pain hypersensitivity. Brain Behav Immun 26: 311-7.
99. Li M, Li Y, Liu X, Gao X, Wang Y., 2012. IL-33 blockade suppresses the development of experimental autoimmune encephalomyelitis in C57BL/6 mice. J Neuroimmunol 247: 25-31.
100. Li X, Montine KS, Keene CD, Montine TJ,. 2015. Different mechanisms of apolipoprotein E isoform-dependent modulation of prostaglandin E2 production and triggering receptor expressed on myeloid cells 2 (TREM2) expression after innate immune activation of microglia. FASEB J 29: 1754-62.
101. Liew FY, Pitman NI, McInnes IB,. 2010. Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat Rev Immunol 10: 103-10.
102. Lindsberg PJ, Strbian D, Karjalainen-Lindsberg ML,. 2010. Mast cells as early responders in the regulation of acute blood-brain barrier changes after cerebral ischemia and hemorrhage. J Cereb Blood Flow Metab 30: 689-702.
103. Lozada A, Maegele M, Stark H, Neugebauer EM, Panula P., 2005. Traumatic brain injury results in mast cell increase and changes in regulation of central histamine receptors. Neuropathol Appl Neurobiol 31: 150-62.
104. Lull ME, Block ML,. 2010. Microglial activation and chronic neurodegeneration. Neurotherapeutics 7: 354-65.
105. Luongo L, Guida F, Imperatore R, Napolitano F, Gatta L, Cristino L, and others. 2014. The A1 adenosine receptor as a new player in microglia physiology. Glia 62: 122-32.
106. Manocha GD, Floden AM, Rausch K, Kulas JA, McGregor BA, Rojanathammanee L, and others. 2016. APP regulates microglial phenotype in a mouse model of Alzheimer's disease. J Neurosci 36: 8471-86.
107. Marchi N, Granata T, Janigro D., 2014. Inflammatory pathways of seizure disorders. Trend Neurosci 37: 55-65.
108. Martini R, Willison H., 2016. Neuroinflammation in the peripheral nerve: cause, modulator, or bystander in peripheral neuropathies? Glia 64: 475-86.
109. Maslinska D, Laure-Kamionowska M, Maslinski KT, Gujski M, Maslinski S., 2007. Distribution of tryptase-containing mast cells and metallothionein reactive astrocytes in human brains with amyloid deposits. Inflamm Res 56: S17-8.
110. Mate I, Madrid JA, De la Fuente M., 2014. Chronobiology of the neuroimmunoendocrine system and aging. Curr Pharm Des 20: 4642-55.
111. Matsuda H, Kawakita K, Kiso Y, Nakano T, Kitamura Y., 1989. Substance P induces granulocyte infiltration through degranulation of mast cells. J Immunol 142: 927-31.
112. Mattila OS, Strbian D, Saksi J, and others. 2011. Cerebral mast cells mediate blood-brain barrier disruption in acute experimental ischemic stroke through perivascular gelatinase activation. Stroke 42: 3600-5.
113. McGeer PL, McGeer EG,. 2013. The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy. Acta Neuropathol 126: 479-97.
114. McKittrick CM, Lawrence CE, Carswell HV,. 2015. Mast cells promote blood brain barrier breakdown and neutrophil infiltration in a mouse model of focal cerebral ischemia. J Cereb Blood Flow Metab 35: 638-47.
115. Medeiros R, LaFerla FM,. 2013. Astrocytes: conductors of the Alzheimer disease neuroinflammatory symphony. Exp Neurol 239: 133-8.
116. Medic N, Lorenzon P, Vita F, Trevisan E, Marchioli A, Soranzo MR, and others. 2010. Mast cell adhesion induces cytoskeletal modifications and programmed cell death in oligodendrocytes. J Neuroimmunol 218: 57-66.
117. Medic N, Vita F, Abbate R, Soranzo MR, Pacor S, Fabbretti E, and others. 2008. Mast cell activation by myelin through scavenger receptor. J Neuroimmunol 200: 27-40.
118. Michaloudi H, Batzios C, Chiotelli M, Grivas I, Papadopoulos GC,. 2008. Mast cells populations fluctuate along the spinal dura mater of the developing rat. Brain Res 1226: 8-17.
119. Michaud M, Balardy L, Moulis G, Gaudin C, Peyrot C, Vellas B, and others. 2013. Proinflammatory cytokines, aging, and age-related diseases. J Am Med Dir Assoc 14: 877-82.
120. Millan MJ, Czlonkowski A, Morris B, Stein C, Arendt R, Huber A, and others. 1988. Inflammation of the hind limb as a model of unilateral, localized pain: influence on multiple opioid systems in the spinal cord of the rat. Pain 35: 299-312.
121. Miller G,. 2005. The dark side of glia. Science 308: 778-81.
122. Milligan ED, Watkins LR,. 2009. Pathological and protective roles of glia in chronic pain. Nat Rev Neurosci 10: 23-36.
123. Monks CR, Freiberg BA, Kupfer H, Sciaky N, Kupfer A., 1998. Three-dimensional segregation of supramolecular activation clusters in T cells. Nature 395: 82-6.
124. Morris MC, Gilliam EA, Li L., 2015. Innate immune programing by endotoxin and its pathological consequences. Front Immunol 5: 680. doi: 10.3389/fimmu.2014.00680.
125. Myers RR, Campana WM, Shubayev VI,. 2006. The role of neuroinflammation in neuropathic pain: mechanisms and therapeutic targets. Drug Discov Today 11: 8-20.
126. Najjar S, Pearlman DM, Alper K, Najjar A, Devinsky O., 2013. Neuroinflammation and psychiatric illness. J Neuroinflammation 10: 43. doi: 10.1186/1742-2094-10-43.
127. Nakae S, Suto H, Iikura M, Kakurai M, Sedgwick JD, Tsai M, and others. 2006. Mast cells enhance T cell activation: importance of mast cell costimulatory molecules and secreted TNF. J Immunol 176: 2238-48.
128. Nakajima A, Watanabe N, Yoshino S, Yagita H, Okumura K, Azuma M., 1997. Requirement of CD28-CD86 co-stimulation in the interaction between antigen-primed T helper type 2 and B cells. Int Immunol 9: 637-44.
129. Nathan C, Ding A., 2010. Nonresolving inflammation. Cell 140: 871-82.
130. Nave KA,. 2010. Myelination and support of axonal integrity by glia. Nature 468: 244-52.
131. Nelissen S, Lemmens E, Geurts N, Kramer P, Maurer M, Hendriks J, and others. 2013. The role of mast cells in neuroinflammation. Acta Neuropathol 125: 637-50.
132. Nguyen M, Pace AJ, Koller BH,. 2005. Age-induced reprogramming of mast cell degranulation. J Immunol 175: 5701-07.
133. Norden DM, Godbout JP,. 2013. Review: microglia of the aged brain: primed to be activated and resistant to regulation. Neuropathol Appl Neurobiol 39: 19-34.
134. Noriega DB, Savelkoul HF,. 2014. Immune dysregulation in autism spectrum disorder. Eur J Pediatr 173: 33-43.
135. Öhrfelt A, Axelsson M, Malmeström C, Novakova L, Heslegrave A, Blennow K, and others. 2016. Soluble TREM-2 in cerebrospinal fluid from patients with multiple sclerosis treated with natalizumab or mitoxantrone. Mult Scler 22: 1587-95. doi: 10.1177/1352458515624558.
136. Old EA, Clark AK, Malcangio M., 2015. The role of glia in the spinal cord in neuropathic and inflammatory pain. Handb Exp Pharmacol 227: 145-70.
137. Orr AG, Orr AL, Li XJ, Gross RE, Traynelis SF,. 2009. Adenosine A(2A) receptor mediates microglial process retraction. Nat Neurosci 12: 872-8.
138. Osipchuk Y, Cahalan M., 1992. Cell-to-cell spread of calcium signals mediated by ATP receptors in mast cells. Nature 359: 241-4.
139. Osterberg A, Boivie J, Thuomas KA,. 2005. Central pain in multiple sclerosis-prevalence and clinical characteristics. Eur J Pain 9: 531-42.
140. Park CK, Xu ZZ, Berta T, Han Q, Chen G, Liu XJ, and others. 2014. Extracellular microRNAs activate nociceptor neurons to elicit pain via TLR7 and TRPA1. Neuron 82: 47-54.
141. Parvathenani LK, Tertyshnikova S, Greco CR, Roberts SB, Robertson B, Posmantur R., 2003. P2X7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer's disease. J Biol Chem 278: 13309-17.
142. Patti GJ, Yanes O, Shriver LP, Courade JP, Tautenhahn R, Manchester M, and others. 2012. Metabolomics implicates altered sphingolipids in chronic pain of neuropathic origin. Nat Chem Biol 8: 232-4.
143. Peferoen L, Kipp M, van der Valk P, van Noort JM, Amor S., 2014. Oligodendrocyte-microglia cross-talk in the central nervous system. Immunology. 141: 302-13.
144. Peferoen LA, Vogel DY, Ummenthum K, Breur M, Heijnen PD, Gerritsen WH, and others. 2015. Activation status of human microglia is dependent on lesion formation stage and remyelination in multiple sclerosis. J Neuropathol Exp Neurol 74: 48-63.
145. Pekny M, Pekna M, Messing A, Steinhäuser C, Lee JM, Parpura V, and others. 2016. Astrocytes: a central element in neurological diseases. Acta Neuropathol 131: 323-45.
146. Pelisch N, Hosomi N, Mori H, Masaki T, Nishiyama A., 2013. RAS inhibition attenuates cognitive impairment by reducing blood- brain barrier permeability in hypertensive subjects. Curr Hypertens Rev 9: 93-8.
147. Peng J, Gu N, Zhou L, Eyo UB, Murugan M, Gan WB, and others. 2016. Microglia and monocytes synergistically promote the transition from acute to chronic pain after nerve injury. Nat Commun 7: 12029. doi: 10.1038/ncomms12029.
148. Perry VH, Andersson PB, Gordon G., 1993. Macrophages and inflammation in the central nervous system. Trends Neurosci 16: 268-73.
149. Perry VH, Holmes C., 2014. Microglial priming in neurodegenerative disease. Nat Rev Neurol 10: 217-24.
150. Pietrzak A, Wierzbicki M, Wiktorska M, Brzezinska-Błaszczyk E., 2011. Surface TLR2 and TLR4 expression on mature rat mast cells can be affected by some bacterial components and proinflammatory cytokines. Mediators Inflamm 2011: 427473. doi: 10.1155/2011/427473.
151. Popiolek-Barczyk K, Mika J., 2016. Targeting the microglial signaling pathways: new insights in the modulation of neuropathic pain. Curr Med Chem 23: 2908-28. doi: 10.2174/0929867323666160607120124.
152. Prinz M, Priller J., 2014. Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease. Nat Rev Neurosci 15: 300-12.
153. Prussin C, Metcalfe DD,. 2003. IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol 111: S486-94.
154. Punzo D, Errico F, Cristino L, Sacchi S, Keller S, Belardo C, and others. 2016. Age-related changes in D-aspartate oxidase promoter methylation control extracellular D-aspartate levels and prevent precocious cell death during brain aging. J Neurosci 36: 3064-78.
155. Ramlackhansingh AF, Brooks DJ, Greenwood RJ, Bose SK, Turkheimer FE, Kinnunen KM, and others. 2011. Inflammation after trauma: microglial activation and traumatic brain injury. Ann Neurol 70: 374-83.
156. Ransohoff RM,. 2016. How neuroinflammation contributes to neurodegeneration. Science 353: 777-82.
157. Rapp JH, Pan XM, Neumann M, Hong M, Hollenbeck K, Liu J., 2008. Microemboli composed of cholesterol crystals disrupt the blood-brain barrier and reduce cognition. Stroke 39: 2354-61.
158. Rawji KS, Mishra MK, Michaels NJ, Rivest S, Stys PK, Yong VW,. 2016. Immunosenescence of microglia and macrophages: impact on the ageing central nervous system. Brain 139: 653-61.
159. Riedel B, Browne K, Silbert B., 2014. Cerebral protection: inflammation, endothelial dysfunction, and postoperative cognitive dysfunction. Curr Opin Anaesthesiol 27: 89-97.
160. Rivat C, Becker C, Blugeot A, Zeau B, Mauborgne A, Pohl M, and others. 2010. Chronic stress induces transient spinal neuroinflammation, triggering sensory hypersensitivity and long-lasting anxiety-induced hyperalgesia. Pain 150: 358-68.
161. Rosa AC,. 2013. The role of histamine in neurogenic inflammation. Br J Pharmacol 170: 38-45.
162. Russi AE, Walker-Caulfield ME, Brown MA,. 2016 a. Mast cell inflammasome activity in the meninges regulates EAE disease severity. Clin Immunol. doi: 10.1016/j.clim.2016.04.009. Epub 21.
163. Russi AE, Walker-Caulfield ME, Guo Y, Lucchinetti CF, Brown MA,. 2016 b. Meningeal mast cell-T cell crosstalk regulates T cell encephalitogenicity. J Autoimmun 73: 100-10. doi: 10.1016/j.jaut.2016.06.015.
164. Safaiyan S, Kannaiyan N, Snaidero N, Brioschi S, Biber K, Yona S, and others. 2016. Age-related myelin degradation burdens the clearance function of microglia during aging. Nat Neurosci 19: 995-8. doi: 10.1038/nn.4325.
165. Sakamoto A, Andoh T, Kuraishi Y., 2016. Involvement of mast cells and proteinase-activated receptor 2 in oxaliplatin-induced mechanical allodynia in mice. Pharmacol Res 2016 105: 84-92.
166. Sastre M, Dewachter I, Landreth GE, Willson TM, Klockgether T, van Leuven F, and others. 2003. Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-γ agonists modulate immunostimulated processing of amyloid precursor protein through regulation of β-secretase. J Neurosci 23: 9796-804.
167. Sayed BA, Christy AL, Walker ME, Brown MA,. 2010. Meningeal mast cells affect early T cell central nervous system infiltration and blood-brain barrier integrity through TNF: a role for neutrophil recruitment? J Immunol 184: 6891-900.
168. Silver R, Curley JP,. 2013. Mast cells on the mind: new insights and opportunities. Trends Neurosci 36: 513-21.
169. Silverman AJ, Sutherland AK, Wilhelm M, Silver R., 2000. Mast cells migrate from blood to brain. J Neurosci 20: 401-8.
170. Sivanandam TM, Thakur MK,. 2012. Traumatic brain injury: a risk factor for Alzheimer's disease. Neurosci Biobehav Rev 36: 1376-81.
171. Skaper SD,. 2015. Commentary. Low-grade non-resolving neuroinflammation: age does matter. CNS Neurol Disord Drug Targets 14: 432-3.
172. Skaper SD, Facci L., 2012. Mast cell-glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide. Philos Trans R Soc Lond B Biol Sci 367: 3312-25.
173. Skaper SD, Debetto P, Giusti P., 2010. The P2X7 purinergic receptor: from physiology to neurological disorders. FASEB J 24: 337-45.
174. Skaper SD, Facci L, Giusti P., 2014. Neuroinflammation, microglia and mast cells in the pathophysiology of neurocognitive disorders: a review. CNS Neurol Disord Drug Targets 13: 1654-66.
175. Skaper SD, Pollock M, Facci L., 2001. Mast cells differentially express and release active high molecular weight neurotrophins. Mol Brain Res 97: 177-85.
176. Skuljec J, Sun H, Pul R, Bénardais K, Ragancokova D, Moharregh-Khiabani D, and others. 2011. CCL5 induces a pro-inflammatory profile in microglia in vitro. Cell Immunol 270: 164-71.
177. Smith JA, Das A, Ray SK, Banik NL,. 2011. Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Res Bull 87: 10-20.
178. Smith BH, Torrance N., 2012. Epidemiology of neuropathic pain and its impact on quality of life. Curr Pain Headache Rep 16: 191-8.
179. Solaro C, Trabucco E, Messmer Uccelli M., 2013. Pain and multiple sclerosis: pathophysiology and treatment. Curr Neurol Neurosci Rep 131: 320. doi: 10.1007/s11910-012-0320-5.
180. Soruri A, Grigat J, Kiafard Z, Zwirner J., 2008, Mast cell activation is characterized by upregulation of a functional anaphylatoxin C5a receptor. BMC Immunol 9: 29. doi: 10.1186/1471-2172-9-29.
181. Sospedra M, Martin R., 2016. Immunology of multiple sclerosis. Semin Neurol 36: 115-27.
182. Strbian D, Tatlisumak T, Ramadan UA, Lindsberg PJ,. 2007. Mast cell blocking reduces brain edema and hematoma volume and improves outcome after experimental intracerebral hemorrhage. J Cereb Blood Flow Metab 27: 795-802.
183. Streit WJ, Braak H, Xue QS, Bechmann I., 2009. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease. Acta Neuropathol 118: 475-85.
184. Suurmond J, van Heemst J, van Heiningen J, Dorjée AL, Schilham MW, van der Beek FB, and others. 2013. Communication between human mast cells and CD4+ T cells through antigen-dependent interactions. Eur J Immunol 43: 1758-68.
185. Tajiri N, Kellogg SL, Shimizu T, Arendash GW, Borlongan CV,. 2013. Traumatic brain injury precipitates cognitive impairment and extracellular Aβ aggregation in Alzheimer's disease transgenic mice. PLoS One 8: e78851. doi: 10.1371/journal.pone.0078851.
186. Takahashi K, Prinz M, Stagi M, Chechneva O, Neumann H., 2007. TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis. PLoS Med 4: e124. doi: 10.1371/journal.pmed.0040124.
187. Terrando N, Brzezinski M, Degos V, Eriksson LI, Kramer JH, Leung JM, and others. 2011. Perioperative cognitive decline in the aging population. Mayo Clin Proc 86: 885-93.
188. Thacker MA, Clark AK, Marchand F, McMahon SB,. 2007. Pathophysiology of peripheral neuropathic pain: immune cells and molecules. Anesth Analg 105: 838-47.
189. Theoharides TC, Baloyannis SJ, Manolidis LS,. 1991. Activated rat peritoneal mast cells can cause syngeneic brain demyelination in vitro. Int J Immunopathol Pharmacol 4: 137-44.
190. Theoharides TC, Kempuraj D, Kourelis T, Manola A., 2008. Human mast cells stimulate activated T cells: implications for multiple sclerosis. Ann N Y Acad Sci 1144: 74-82.
191. Theoharides TC, Petra AI, Taracanova A, Panagiotidou S, Conti P., 2015 a. Targeting IL-33 in autoimmunity and inflammation. J Pharmacol Exp Ther 354: 24-31.
192. Theoharides TC, Stewart JM, Hatziagelaki E, Kolaitis G., 2015 b. Brain "fog," inflammation and obesity: key aspects of neuropsychiatric disorders improved by luteolin. Front Neurosci 9: 225. doi: 10.3389/fnins.2015.00225.
193. Theoharides TC, Stewart JM, Panagiotidou S, Melamed I., 2016. Mast cells, brain inflammation and autism. Eur J Pharmacol 778: 96-102.
194. Theoharides TC, Zhang B, Kempuraj D, Tagen M, Vasiadi M, Angelidou A, and others. 2010. IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin. Proc Natl Acad Sci U S A 107: 4448-53.
195. Tsuboi I, Harada T, Hirabayashi Y, Kanno J, Inoue T, Aizawa S., 2012. Age-related decline of mast cell regeneration in senescence-accelerated mice (SAMP1) after chemical myeloablation due to senescent stromal cell impairment. Exp Biol Med (Maywood) 237: 1289-97.
196. Tsuda M,. 2016. P2 receptors, microglial cytokines and chemokines, and neuropathic pain. J Neurosci Res. doi: 10.1002/jnr.23816. Epub 4.
197. Ulmann L, Hatcher JP, Hughes JP, Chaumont S, Green PJ, Conquet F, and others. 2008. Up-regulation of P2X4 receptors on spinal microglia after peripheral nerve injury mediates BDNF release and neuropathic pain. J Neurosci 28: 11263-68
198. van Hecke O, Austin SK, Khan RA, Smith BH, Torrance N., 2014. Neuropathic pain in the general population: a systematic review of epidemiological studies. Pain 155: 654-62.
199. Varma R, Campi G, Yokosuka T, Saito T, Dustin ML,. 2006. T cell receptor-proximal signals are sustained in peripheral microclusters and terminated in the central supramolecular activation cluster. Immunity 25: 117-27.
200. von Büdingen HC, Mei F, Greenfield A, Jahn S, Shen YA, Reid HH, and others. 2015. The myelin oligodendrocyte glycoprotein directly binds nerve growth factor to modulate central axon circuitry. J Cell Biol 210: 891-8.
201. Vyas H, Krishnaswamy G., 2006. Paul Ehrlich's "Mastzellen"-from aniline dyes to DNA chip arrays: a historical review of developments in mast cell research. Methods Mol Biol 315: 3-11.
202. Wang M, Wang X, Zhao L, Ma W, Rodriguez IR, Fariss RN, and others. 2014. Macroglia-microglia interactions via TSPO signaling regulates microglial activation in the mouse retina. J Neurosci 34: 3793-806.
203. Wang Y, Huang J, Li Y, Yang GY,. 2012. Roles of chemokine CXCL12 and its receptors in ischemic stroke. Curr Drug Targets 13: 166-72.
204. Wardlaw AJ, Moqbel R, Cromwell O, Kay AB,. 1986. Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. J Clin Invest 78: 1701-6.
205. Watkins LR, Milligan ED, Maier SF,. 2003. Glial proinflammatory cytokines mediate exaggerated pain states: implications for clinical pain. Adv Exp Med Biol 521: 1-21.
206. Wohleb ES, Franklin T, Iwata M, Duman RS,. 2016. Integrating neuroimmune systems in the neurobiology of depression. Nat Rev Neurosci 17: 497-511.
207. Xanthos DN, Gaderer S, Drdla R, Nuro E, Abramova A, Ellmeier W, and others. 2011. Central nervous system mast cells in peripheral inflammatory nociception. Mol Pain 7: 42. doi: 10.1186/1744-8069-7-42.
208. Xie F, Zhang JC, Fu H, Chen J., 2013. Age-related decline of myelin proteins is highly correlated with activation of astrocytes and microglia in the rat CNS. Int J Mol Med 32: 1021-8.
209. Young KM, Psachoulia K, Tripathi RB, Dunn SJ, Cossell L, Attwell D, and others. Oligodendrocyte dynamics in the healthy adult CNS: evidence for myelin remodeling. Neuron 77: 873-85.
210. Yuan H, Zhu X, Zhou S, Chen Q, Zhu X, Ma X, and others. 2010. Role of mast cell activation in inducing microglial cells to release neurotrophin. J Neurosci Res 88: 1348-54.
211. Zarpelon AC, Rodrigues FC, Lopes AH, Souza GR, Carvalho TT, Pinto LG, and others. 2016. Spinal cord oligodendrocyte-derived alarmin IL-33 mediates neuropathic pain. FASEB J. 30: 54-65.
212. Zeis T, Enz L, Schaeren-Wiemers N., 2016. The immunomodulatory oligodendrocyte. Brain Res 1641: 139-48.
213. Zhang H, Yang H, He S., 2010. TNF increases expression of IL-4 and PARs in mast cells. Cell Physiol Biochem 26: 327-36.
214. Zhang S, Dong H, Zhang X, Li N, Sun J, Qian Y., 2016. Cerebral mast cells contribute to postoperative cognitive dysfunction by promoting blood brain barrier disruption. Behav Brain Res 298: 158-66.
215. Zhang ZG, Zhang L, Jiang Q, Zhang R, Davies K, Powers C, and others. 2000. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J Clin Invest 106: 829-38.
216. Zuo Y, Perkins NM, Tracey DJ, Geczy CL,. 2003. Inflammation and hyperalgesia induced by nerve injury in the rat: a key role of mast cells. Pain 105: 467-79.